- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Respiratory syncytial virus (RSV)
- Meeting Date: July 2025
- Public Summary Document (PSD) November 2024 July 2025 PBAC Meetings - (PDF 2MB)
- Public Summary Document (PSD) November 2024 July 2025 PBAC Meetings - (Word 1.4MB)
Related Public Summary Documents
